PMID- 24228179 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20140624 LR - 20211021 IS - 2090-3014 (Print) IS - 2090-3022 (Electronic) IS - 2090-3022 (Linking) VI - 2013 DP - 2013 TI - Targeting antigens to dendritic cell receptors for vaccine development. PG - 869718 LID - 10.1155/2013/869718 [doi] LID - 869718 AB - Dendritic cells (DCs) are highly specialized antigen presenting cells of the immune system which play a key role in regulating immune responses. Depending on the method of antigen delivery, DCs stimulate immune responses or induce tolerance. As a consequence of the dual function of DCs, DCs are studied in the context of immunotherapy for both cancer and autoimmune diseases. In vaccine development, a major aim is to induce strong, specific T-cell responses. This is achieved by targeting antigen to cell surface molecules on DCs that efficiently channel the antigen into endocytic compartments for loading onto MHC molecules and stimulation of T-cell responses. The most attractive cell surface receptors, expressed on DCs used as targets for antigen delivery for cancer and other diseases, are discussed. FAU - Apostolopoulos, Vasso AU - Apostolopoulos V AD - VA Consulting Services, Melbourne, VIC, Australia ; College of Health and Biomedicine, Victoria University, VIC, Australia. FAU - Thalhammer, Theresia AU - Thalhammer T FAU - Tzakos, Andreas G AU - Tzakos AG FAU - Stojanovska, Lily AU - Stojanovska L LA - eng PT - Journal Article PT - Review DEP - 20131008 PL - Egypt TA - J Drug Deliv JT - Journal of drug delivery JID - 101553818 PMC - PMC3817681 EDAT- 2013/11/15 06:00 MHDA- 2013/11/15 06:01 PMCR- 2013/10/08 CRDT- 2013/11/15 06:00 PHST- 2012/12/12 00:00 [received] PHST- 2013/07/11 00:00 [accepted] PHST- 2013/11/15 06:00 [entrez] PHST- 2013/11/15 06:00 [pubmed] PHST- 2013/11/15 06:01 [medline] PHST- 2013/10/08 00:00 [pmc-release] AID - 10.1155/2013/869718 [doi] PST - ppublish SO - J Drug Deliv. 2013;2013:869718. doi: 10.1155/2013/869718. Epub 2013 Oct 8.